- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01219946
A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD) (COPD Language)
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.
Chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in lung function and increased symptoms such as breathlessness/dyspnoea, cough and expectoration.
Even though subjective in nature, the symptomatology of COPD and mainly that of breathlessness/dyspnoea has been studied with the use of objective measurement tools. Taking into consideration that the symptoms experienced by the patient who suffers from a progressive disease such as COPD can only be perceived and interpreted by the patient him- or herself, and thus difficult to be quantified, COPD remains a challenge in clinical research.
Therefore, there is a need to carry out qualitative studies that will provide insight into the wide spectrum of COPD symptomatology from the patient's perspective. In addition, a further mapping of the impact that COPD symptoms' perception has on a patient's life is required, as well as of the different pathways through which symptoms' perception is interpreted regarding the limitations of daily living activities, and the subsequent impact on disease management. The more the physician learns on the embodied experience of COPD, the better he/she may assist the patient in achieving optimal COPD management.
Thus this cross-sectional observational study was designed aiming to obtain these data. Specifically, the study aims to evaluate the most frequently used words by the patients and the physicians to express the symptoms of COPD as well as the limitation of activities that it causes.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Attiki
-
Athina, Attiki, Grecia
- Research Site
-
Kalithea, Attiki, Grecia
- Research Site
-
Marousi, Attiki, Grecia
- Research Site
-
Megara, Attiki, Grecia
- Research Site
-
Nea Ionia, Attiki, Grecia
- Research Site
-
Nea Makri, Attiki, Grecia
- Research Site
-
Piraeus, Attiki, Grecia
- Research Site
-
-
Dodekanisa
-
Rodos, Dodekanisa, Grecia
- Research Site
-
-
Eptanisa
-
Kerkyra, Eptanisa, Grecia
- Research Site
-
-
Ipiros
-
Ioannina, Ipiros, Grecia
- Research Site
-
-
Kriti
-
Chania, Kriti, Grecia
- Research Site
-
Heraklion, Kriti, Grecia
- Research Site
-
-
Kyklades
-
Larisa, Kyklades, Grecia
- Research Site
-
Mykonos, Kyklades, Grecia
- Research Site
-
-
Makedonia
-
Alexandria, Makedonia, Grecia
- Research Site
-
Drama, Makedonia, Grecia
- Research Site
-
Florina, Makedonia, Grecia
- Research Site
-
Katerini, Makedonia, Grecia
- Research Site
-
Kavala, Makedonia, Grecia
- Research Site
-
Kozani, Makedonia, Grecia
- Research Site
-
Serres, Makedonia, Grecia
- Research Site
-
Thesaloniki, Makedonia, Grecia
- Research Site
-
-
Peloponisos
-
Krestena, Peloponisos, Grecia
- Research Site
-
Lechaina, Peloponisos, Grecia
- Research Site
-
Patra, Peloponisos, Grecia
- Research Site
-
Skala, Peloponisos, Grecia
- Research Site
-
-
Sterea
-
Agrinio, Sterea, Grecia
- Research Site
-
Halkida, Sterea, Grecia
- Research Site
-
Itea, Sterea, Grecia
- Research Site
-
Livadia, Sterea, Grecia
- Research Site
-
-
Thesalia
-
Volos, Thesalia, Grecia
- Research Site
-
-
Traki
-
Xanthi, Traki, Grecia
- Research Site
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Aged 45-75 years
- Current or former smokers
- Known history of COPD for at least 6 months before enrolment into the study documented by spirometry (FEV1 /FVC <70%)
- Patients with stable COPD (no exacerbation within the last month before enrolment into the study) under treatment with a long-acting inhaled bronchodilator (LABA and/or LAMA) alone or in combination with an inhaled corticosteroid
- Written consent for participation in the study
- Patients who are able to complete by themselves in Greek a questionnaire on COPD.
Exclusion Criteria:
- Patients with diagnosed Asthma
- Patients with any psychiatric, neurological or other disorder render them unable to complete the COPD questionnaire by themselves
- The patient participates in another study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
---|
1
Patients with Chronic Obstructive Pulmonary Disease
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
Words used by the patients and the physicians to express the symptoms of COPD as well as the limitations of patients' daily living activities caused by COPD.
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
---|---|
Stato civile
Lasso di tempo: Fine del reclutamento (periodo di tempo stimato: 2,5 mesi)
|
Fine del reclutamento (periodo di tempo stimato: 2,5 mesi)
|
Occupazione
Lasso di tempo: Fine del reclutamento (periodo di tempo stimato: 2,5 mesi)
|
Fine del reclutamento (periodo di tempo stimato: 2,5 mesi)
|
Age
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Gender
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Place of residence
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Native language
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Educational level
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Co-morbidities
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Years / months since COPD diagnosis and years with COPD symptoms
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Smoking history
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Number of exacerbations during the last year
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Current therapy
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
CCQ score
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Compliance with therapy
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Actions/therapeutic recommendations by the physician associated with each chosen word that express the chronic daily symptoms
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Scale for the assessment of the severity of the relevant symptoms
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Actions/therapeutic recommendations by the physician when any of the symptoms worsen
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Severity scale regarding how the patient experiences each of the chosen words that express the chronic daily symptoms
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Related actions initiated by the patient regarding chronic daily symptoms
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Related actions initiated by the patient when the symptoms worsen.
Lasso di tempo: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Direttore dello studio: Panagiotis Pontikis
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- NIS-RGR-DUM-2010/1
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .